<DOC>
	<DOCNO>NCT01741012</DOCNO>
	<brief_summary>Cervical neoplasia increase woman SLE likely due cervical infection human papilloma virus ( HPV ) . 70 % cervical cancer cause HPV type 16 18 . Gardasil vaccine prevents cervical infection HPV type 16 18 . Thus lupus patient ( susceptible cervical cancer ) may benefit get Gardasil vaccine prevent cervical cancer . Vaccines generally safe efficacious SLE study do use vaccine SLE . The investigator hypothesize Gardasil vaccine safe effective SLE . This study look vaccine safety patient mild moderate minimally active inactive SLE measure well make protective antibody receive vaccine . In word check well vaccine work SLE .</brief_summary>
	<brief_title>Study Determine Gardasil Vaccine Safe Effective Lupus Patients</brief_title>
	<detailed_description>To gather safety information adverse event use Gardasil® mild moderate minimally active inactive SLE . To gather information SLE disease activity flare vaccination Gardasil® . To gather information immunogenicity development protective anti HPV antibodies SLE vaccination Gardasil® .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Diagnosis systemic lupus erythematosis ( SLE ) American College Rheumatology ( ACR ) Criteria . History positive antinuclear antibody ( ANA ) test result time past . 40 participant history mild moderate SLE disease Minimally active inactive SLE disease , i.e. , SELENDASLEDAI ≤2 start study . Age ≥ 18 year ≤ 50 year . Gender : female Ability provide inform consent . Maintenance Prednisone dose ≤ 15 mg/day . Plaquenil ≤ 400 mg/day . Hypersensitivity vaccine component Active infection include limited human immunodeficiency virus ( HIV positive ) , Hepatitis B C , tuberculosis . Positive purify protein derivative ( PPD ) test result without evidence prior treatment administration bacillus CalmetteGuerin ( BCG ) vaccine . A positive PPD define ≥ 5 mm induration 2438 hour receive 5TU PPD . Pregnancy desire become pregnant study period . Breast feeding . Inability complete immunization series . Received blood product component previous 6 month enrollment . Received inactivated vaccine product within 14 day enrollment . Received live vaccine product within 21 day enrollment . Fever ( temperature &gt; 100°F ) time enrollment . Inability provide informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Lupus</keyword>
</DOC>